Author
Listed:
- Marta Łuksza
(The Simons Center for Systems Biology, Institute for Advanced Study)
- Nadeem Riaz
(Memorial Sloan Kettering Cancer Center
Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center)
- Vladimir Makarov
(Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)
- Vinod P. Balachandran
(Memorial Sloan Kettering Cancer Center
David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center)
- Matthew D. Hellmann
(Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College, Cornell University)
- Alexander Solovyov
(Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Naiyer A. Rizvi
(Columbia University Medical Center)
- Taha Merghoub
(Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center
Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center
Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center)
- Arnold J. Levine
(The Simons Center for Systems Biology, Institute for Advanced Study)
- Timothy A. Chan
(Memorial Sloan Kettering Cancer Center
Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center)
- Jedd D. Wolchok
(Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center
Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center)
- Benjamin D. Greenbaum
(Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
Abstract
An immune fitness model for tumours under checkpoint blockade immunotherapy is proposed, through which the authors show that the presentation and recognition properties of dominant neoantigens distributed over tumour subclones are predictive of response in melanoma and lung cancer cohorts.
Suggested Citation
Marta Łuksza & Nadeem Riaz & Vladimir Makarov & Vinod P. Balachandran & Matthew D. Hellmann & Alexander Solovyov & Naiyer A. Rizvi & Taha Merghoub & Arnold J. Levine & Timothy A. Chan & Jedd D. Wolcho, 2017.
"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy,"
Nature, Nature, vol. 551(7681), pages 517-520, November.
Handle:
RePEc:nat:nature:v:551:y:2017:i:7681:d:10.1038_nature24473
DOI: 10.1038/nature24473
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:551:y:2017:i:7681:d:10.1038_nature24473. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.